In summary, our study demonstrated that RasGRP1 is an essential regulator that promotes the inflammatory response by increasing IL-6 production and suppressing liver cancer cell growth via inhibition of EGFR-SOS1-Ras-AKT signalling pathway activation. The gene discussed is RASGRP1; the disease is liver cancer.